Case Report

Combined antiretroviral and antituberculosis drug resistance following incarceration

Katharine Elizabeth Stott, Tulio de Oliveira, Richard John Lessells
Southern African Journal of HIV Medicine | Vol 14, No 3 | a67 | DOI: https://doi.org/10.4102/sajhivmed.v14i3.67 | © 2013 Katharine Elizabeth Stott, Tulio de Oliveira, Richard John Lessells | This work is licensed under CC Attribution 4.0
Submitted: 12 December 2013 | Published: 17 September 2013

About the author(s)

Katharine Elizabeth Stott, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa, South Africa
Tulio de Oliveira, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa; Research Department of Infection, University College London, London, United Kingdom, South Africa
Richard John Lessells, Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom, South Africa


Share this article

Bookmark and Share

Abstract

We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights the urgent need for improved integration of HIV/TB control strategies within prison health systems and within the broader public health framework.


Keywords

Tuberculosis; multidrug-resistant; HIV-1; anti-HIV agents; drug resistance

Metrics

Total abstract views: 1761
Total article views: 2740

 

Crossref Citations

1. Do Incarcerated Populations Serve as a Reservoir for Tuberculosis in South Africa?
Alana Sharp, J. Travis Donahoe, Amanda Milliken, Jacqueline Barocio, Salome Charalambous, Zoë M. McLaren
The American Journal of Tropical Medicine and Hygiene  vol: 99  issue: 6  first page: 1390  year: 2018  
doi: 10.4269/ajtmh.17-0652